Arkolith/Insider Trading/VIR/Form 4

SVF Endurance (Cayman) Ltd

10% OwnerVir Biotechnology, Inc. (VIR) · full profile →Form 4 · filed Oct 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$180K
Net Open-Market Flow
-$180K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 16, 2025Sell(S)13K$6.10$78K15.3M
Oct 15, 2025Sell(S)17K$6.07$101K15.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-018462) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML